193 related articles for article (PubMed ID: 25801780)
1. Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.
Rhodes NJ; Liu J; McLaughlin MM; Qi C; Scheetz MH
Diagn Microbiol Infect Dis; 2015 Jun; 82(2):165-71. PubMed ID: 25801780
[TBL] [Abstract][Full Text] [Related]
2. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
[TBL] [Abstract][Full Text] [Related]
3. Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.
Rhodes NJ; Kuti JL; Nicolau DP; Van Wart S; Nicasio AM; Liu J; Lee BJ; Neely MN; Scheetz MH
Antimicrob Agents Chemother; 2015 Dec; 60(3):1401-10. PubMed ID: 26666929
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.
Esterly JS; Wagner J; McLaughlin MM; Postelnick MJ; Qi C; Scheetz MH
Antimicrob Agents Chemother; 2012 Sep; 56(9):4885-90. PubMed ID: 22777044
[TBL] [Abstract][Full Text] [Related]
5. Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.
Bhat SV; Peleg AY; Lodise TP; Shutt KA; Capitano B; Potoski BA; Paterson DL
Antimicrob Agents Chemother; 2007 Dec; 51(12):4390-5. PubMed ID: 17938179
[TBL] [Abstract][Full Text] [Related]
6. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.
Altshuler J; Guervil DJ; Ericsson CD; Wanger A; Aitken SL; Ostrosky-Zeichner L
J Pharm Pract; 2018 Feb; 31(1):34-39. PubMed ID: 29278990
[TBL] [Abstract][Full Text] [Related]
8. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
9. Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study.
Su TY; Ye JJ; Yang CC; Huang CT; Chia JH; Lee MH
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):52. PubMed ID: 28738848
[TBL] [Abstract][Full Text] [Related]
10. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
Clin Infect Dis; 2013 Feb; 56(4):488-95. PubMed ID: 23090931
[TBL] [Abstract][Full Text] [Related]
11. Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
Gibson GA; Bauer SR; Neuner EA; Bass SN; Lam SW
Antimicrob Agents Chemother; 2016 Jan; 60(1):431-6. PubMed ID: 26525802
[TBL] [Abstract][Full Text] [Related]
12. Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.
McLaughlin MM; Miglis C; Skoglund E; Wagner J; Advincula MR; Scheetz MH
J Glob Antimicrob Resist; 2018 Jun; 13():261-263. PubMed ID: 29432939
[TBL] [Abstract][Full Text] [Related]
13. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.
Georges B; Conil JM; Cougot P; Decun JF; Archambaud M; Seguin T; Chabanon G; Virenque C; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):360-9. PubMed ID: 16119511
[TBL] [Abstract][Full Text] [Related]
14. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
15. Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.
Defife R; Scheetz MH; Feinglass JM; Postelnick MJ; Scarsi KK
Antimicrob Agents Chemother; 2009 Mar; 53(3):1074-9. PubMed ID: 19075047
[TBL] [Abstract][Full Text] [Related]
16. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
[TBL] [Abstract][Full Text] [Related]
17. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
Saghir S; Faiz M; Saleem M; Younus A; Aziz H
Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections.
Lizza BD; Rhodes NJ; Esterly JS; Toy C; Lopez J; Scheetz MH
J Infect Chemother; 2016 Oct; 22(10):671-6. PubMed ID: 27590417
[TBL] [Abstract][Full Text] [Related]
19. A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
Ratliff AR; Gentry CA; Williams RJ
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):376-381. PubMed ID: 28087171
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of cefepime in patients with Gram-negative infections.
Tam VH; McKinnon PS; Akins RL; Rybak MJ; Drusano GL
J Antimicrob Chemother; 2002 Sep; 50(3):425-8. PubMed ID: 12205070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
